Magnitude and factors associated with anxiety and depression among patients with breast cancer in central Ethiopia: A cross-sectional study.
Ethiopia
anxiety
breast cancer
depression
mental health
public health
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
05
2022
accepted:
03
08
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
Patients with breast cancer are assumed to be susceptible to anxiety and depression, while there is a lack of evidence about the epidemiology and underlying factors in Ethiopia. Hence, we aimed to assess the prevalence and predictors of anxiety and depression among patients with breast cancer in Ethiopia. An institutional-based cross-sectional study was conducted among patients with breast cancer who were attending treatment at the Oncology Center of the Tikur Anbessa Specialized Hospital, the largest referral teaching hospital in Ethiopia. The Hospital Anxiety and Depression Scale (HDAS) was used to evaluate the anxiety and depression status of the participants, and a structured questionnaire was used to collect sociodemographic, socioeconomic, and clinical data from the participants. Medical records of the participants were reviewed to collect and correlate information about the grade and stage of cancer. An analysis was done using STATA 15.1. The study included 333 randomly selected participants, of which 35.4% were on stage III and 33% on stage II, and 67.9% were on chemotherapy and surgery. The prevalence of anxiety and depression were 60.7 and 58.6%, respectively. Poor patient-provider interaction (adjusted odds ratio [AOR] = 4.5, 95% CI: 2.49, 8.12) and having no financial support (AOR = 2.83, 95% CI: 1.63, 4.91) were the significant predictors of anxiety. Age >49 years (AOR = 0.48, 95% CI: 0.25, 0.90), poor patient-provider interactions (AOR = 3.36, 95% CI: 1.87, 6.02), and having no financial support (AOR = 3.36, 95% CI: 1.95, 5.79) were the significant predictors of depression. In this study, the prevalence of anxiety and depression was high among patients with breast cancer, and the lack of financial support and poor patient-provider interactions were significant predictors of anxiety and depression among these groups of patients. Patients with cancer need regular screening for mental health and better emotional support from their healthcare providers and families to prevent and treat anxiety and depression.
Sections du résumé
Background
UNASSIGNED
Patients with breast cancer are assumed to be susceptible to anxiety and depression, while there is a lack of evidence about the epidemiology and underlying factors in Ethiopia. Hence, we aimed to assess the prevalence and predictors of anxiety and depression among patients with breast cancer in Ethiopia.
Method
UNASSIGNED
An institutional-based cross-sectional study was conducted among patients with breast cancer who were attending treatment at the Oncology Center of the Tikur Anbessa Specialized Hospital, the largest referral teaching hospital in Ethiopia. The Hospital Anxiety and Depression Scale (HDAS) was used to evaluate the anxiety and depression status of the participants, and a structured questionnaire was used to collect sociodemographic, socioeconomic, and clinical data from the participants. Medical records of the participants were reviewed to collect and correlate information about the grade and stage of cancer. An analysis was done using STATA 15.1.
Results
UNASSIGNED
The study included 333 randomly selected participants, of which 35.4% were on stage III and 33% on stage II, and 67.9% were on chemotherapy and surgery. The prevalence of anxiety and depression were 60.7 and 58.6%, respectively. Poor patient-provider interaction (adjusted odds ratio [AOR] = 4.5, 95% CI: 2.49, 8.12) and having no financial support (AOR = 2.83, 95% CI: 1.63, 4.91) were the significant predictors of anxiety. Age >49 years (AOR = 0.48, 95% CI: 0.25, 0.90), poor patient-provider interactions (AOR = 3.36, 95% CI: 1.87, 6.02), and having no financial support (AOR = 3.36, 95% CI: 1.95, 5.79) were the significant predictors of depression.
Conclusion
UNASSIGNED
In this study, the prevalence of anxiety and depression was high among patients with breast cancer, and the lack of financial support and poor patient-provider interactions were significant predictors of anxiety and depression among these groups of patients. Patients with cancer need regular screening for mental health and better emotional support from their healthcare providers and families to prevent and treat anxiety and depression.
Identifiants
pubmed: 36090359
doi: 10.3389/fpsyt.2022.957592
pmc: PMC9458879
doi:
Types de publication
Journal Article
Langues
eng
Pagination
957592Informations de copyright
Copyright © 2022 Belay, Labisso, Tigeneh, Kaba and Haileselassie.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Psychooncology. 2004 Oct;13(10):729-39
pubmed: 15386642
J Clin Oncol. 2009 Feb 10;27(5):699-705
pubmed: 19114706
Psychooncology. 2004 Oct;13(10):740-52
pubmed: 15386646
BMJ Open. 2022 Jan 21;12(1):e051317
pubmed: 35063957
Psychol Med. 2013 May;43(5):897-910
pubmed: 22781489
Asian Pac J Cancer Prev. 2015;16(9):4031-5
pubmed: 25987081
Lancet Oncol. 2013 Apr;14(4):289-90
pubmed: 23561741
Psychooncology. 2008 Nov;17(11):1061-72
pubmed: 18561287
Cancers (Basel). 2021 Aug 25;13(17):
pubmed: 34503097
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1661-1669
pubmed: 29938451
Stress Health. 2012 Dec;28(5):362-7
pubmed: 22972767
Psychiatr Danub. 2017 Sep;29(3):330-344
pubmed: 28949314
BMC Cancer. 2019 Aug 27;19(1):836
pubmed: 31455282
Caspian J Intern Med. 2014 Summer;5(3):167-70
pubmed: 25202445
Arch Gen Psychiatry. 2011 Jul;68(7):692-700
pubmed: 21727253
Ann Oncol. 2013 Feb;24(2):291-300
pubmed: 23041586
Breast Cancer Res Treat. 2019 Aug;176(3):519-533
pubmed: 31087199
Support Care Cancer. 2008 Jul;16(7):791-801
pubmed: 18204940
JCO Glob Oncol. 2021 Jul;7:1233-1250
pubmed: 34343029
J Glob Health. 2018 Jun;8(1):010419
pubmed: 29740502
BMJ. 2005 Mar 26;330(7493):702
pubmed: 15695497
Indian J Psychol Med. 2012 Apr;34(2):119-23
pubmed: 23162185
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):355-61
pubmed: 19458878
Psychooncology. 2014 Feb;23(2):121-30
pubmed: 24105788
J Health Psychol. 2014 Jul;19(7):836-46
pubmed: 23520353
PLoS One. 2011 Jan 25;6(1):e16049
pubmed: 21283565
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Afr Health Sci. 2011 Sep;11(3):341-5
pubmed: 22275922
Breast. 2017 Feb;31:26-33
pubmed: 27810696
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593